ArticleBMC complementary medicine and therapies2025
Evaluation of NTD-O2, a Ghanaian herbal medicine, for onchocerciasis and animal African trypanosomiasis.
Article in BMC complementary medicine and therapies, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundHerbal medicine remains central to primary healthcare in Ghana due to its accessibility and perceived safety. NTD-O2 is an aqueous herbal formulation derived from Xylopia aethiopica fruits and Bambusa vulgaris leaves, traditionally used for managing onchocerciasis, a neglected tropical disease (NTD) endemic to the country. This study evaluated the antionchocercal activity of NTD-O2 and assessed isolated compounds from the formulation and its source plants for activity against animal African trypanosomiasis, another prevalent NTD.
methodsDichloromethane (DCM) and butanol (BuOH) extracts of NTD-O2 were screened in vitro against Onchocerca ochengi and Trypanosoma brucei brucei. Bioassay-guided fractionation, coupled with spectroscopic and spectrometric techniques, facilitated structural elucidation of isolated compounds. Potential mechanisms of action were explored through in silico molecular docking.
resultsBoth NTD-O2 extracts achieved 100% inhibition of adult male O. ochengi motility. Activity against female worms was moderate (NTD-DCM: 61.0 ± 1.8%; NTD-BuOH: 56.6 ± 4.4%), and weaker against microfilariae (NTD-DCM: 50 ± 0%; NTD-BuOH: 0%). Antitrypanosomal activity was more pronounced, with IC
conclusionNTD-O2 demonstrated selective antionchocercal and moderate antitrypanosomal activities, validating aspects of its traditional use. However, the presence of phthalate, a compound of known toxicological risks, and the absence of key plant-derived constituents raise concerns about formulation consistency and safety. These findings underscore the need for routine quality control and safety monitoring of herbal medicines to ensure efficacy and public health protection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.